🇺🇸 FDA
Pipeline program

[18F]F-AraG

14-14488

Phase 1 small_molecule active

Quick answer

[18F]F-AraG for Cancer is a Phase 1 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Cancer
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials